Meningococcal serogroup B vaccines: will they live up to expectations? - Wikidata - wikimedia - TriplyDB

Meningococcal serogroup B vaccines: will they live up to expectations?

Meningococcal serogroup B vaccines: will they live up to expectations?

http://www.wikidata.org/entity/Q38726967

about

Meningococcal B vaccine and the vision of a meningitis free world Use of a molecular decoy to segregate transport from antigenicity in the FrpB iron transporter from Neisseria meningitidis Adjuvant efficacy of mOMV against avian influenza virus infection in mice.Cysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine development Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2.Refolding, purification and crystallization of the FrpB outer membrane iron transporter from Neisseria meningitidis A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program.Persistence of antibodies in adolescents 18-24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.

P2860

Q26770696-817DC34D-BF25-4051-A0A0-A93DB40EBB67 Q27676685-74B9E0FB-D662-4F95-9D7E-CF25FCE065C1 Q30219688-705E8DB4-C17A-41A7-8782-56922E21E6BB Q34571107-6F7E4DA6-0897-4D01-998B-34720AB8BB1A Q34761285-DE7B3E7E-0168-4A95-A3BE-09789D4E9EF0 Q35518459-9B1E3392-548B-460C-A395-607947E2FEE9 Q35742066-612C5788-96BC-4B9C-8ACF-18B49B99DD92 Q37471668-FFE0541D-9DD4-48A3-83ED-6BE29F3B2429 Q37694840-BBCBFE8C-A0EA-4803-8CCB-AC829B7111D4 Q37956384-16AE658E-E917-4568-8AD0-6708F6EA70D2

P2860

Meningococcal serogroup B vaccines: will they live up to expectations?

http://www.wikidata.org/entity/Q38726967

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Meningococcal serogroup B vaccines: will they live up to expectations?

@en

type

label

Meningococcal serogroup B vaccines: will they live up to expectations?

@en

prefLabel

Meningococcal serogroup B vaccines: will they live up to expectations?

@en

P1433

Q38726967-23FF1675-E49B-4DF5-A53C-ACBE61C724AC

P1476

Q38726967-4593403E-8FEF-4A10-BC43-5048B31E9B87

P2093

Q38726967-281EE96A-8B86-432F-A4E7-50E84CE5709B

Q38726967-8621FD7E-F60A-490B-BB17-D69CCE8A23EA

P2860

Q38726967-0D137422-4791-4D26-8DBE-01D577E519B5

Q38726967-0D568174-38AD-46E6-B4A8-B528CBB2A022

Q38726967-0D92FF2B-8D46-49CC-A221-255BDF09936C

Q38726967-130AA136-004A-413D-ACF9-8460120E3CD5

Q38726967-24B5451A-4069-4218-B2FD-8E4F7D958C06

Q38726967-4718B763-D6DB-447A-A87F-357EFD62E999

Q38726967-5364BFF3-4485-4CBA-A9FC-503570A66475

Q38726967-56660DD5-8350-4B78-9270-9494E9EC4B31

Q38726967-58108245-6612-475D-BA26-C8A8B9A7D4F8

Q38726967-6E6F8712-EF04-47BE-824E-59C63067F2BA

P304

Q38726967-F5769532-20D5-48DF-9FF2-99FC7B448C88

P31

Q38726967-0AF5C415-214C-40B9-A11B-9230B6970083

Q38726967-3ceacb20-fa2b-4548-a233-f4a04d36c879

P356

Q38726967-453D0E7A-45CF-41CE-9CC2-950C040DC2F4

P433

Q38726967-D2F0923A-9121-449A-B110-3AFE04BD7A24

P478

Q38726967-D5AE7BF1-2D6E-4B4E-9140-2DDCEA385AA7

P50

Q38726967-157FFFBD-BA0A-43B7-BBD5-0A18070A8353

P577

Q38726967-54BB38F5-F8DD-416E-98EB-3CF8DE00745F

P5875

Q38726967-9779518D-47FB-451C-BB24-A58CF8DDF8B3

P698

Q38726967-311CA019-3052-4FBC-9099-CD8C8C2BCDC2

P932

Q38726967-B2501FB7-9986-495F-8A12-54AA6F9AC357

P356

P1433

Expert Review of Vaccines

P1476

Meningococcal serogroup B vaccines: will they live up to expectations?

@en

P2093

Jan T Poolman

http://www.w3.org/2001/XMLSchema#string

Wendell D Zollinger

http://www.w3.org/2001/XMLSchema#string

P2860

Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates.

Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific.

Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents.

A universal vaccine for serogroup B meningococcus

Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis.

Molecular typing of meningococci: recommendations for target choice and nomenclature.

Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2

Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.

Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.

Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.

P304

559-561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.11.41

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51158445

http://www.w3.org/2001/XMLSchema#string

P698

21604975

http://www.w3.org/2001/XMLSchema#string

P932

3985070

http://www.w3.org/2001/XMLSchema#string